Back to Search

STEPHEN SALLAN, MD

MD

Pediatric Hematology & Oncology Physician

NPI: 1467421800Individual

Specialties, Licenses & Credentials

Pediatric Hematology & Oncology PhysicianPrimary

Pediatrics — Pediatric Hematology-Oncology

Code: 2080P0207X

33196(MA)

Research & Publications (20)

Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia.
PMID 17124051·Hematology Am Soc Hematol Educ Program·2006
6-review
Wise up: do not do it without protection!
PMID 16206201·Pediatr Blood Cancer·2005
8-other
Management of acute tumor lysis syndrome.
PMID 11343272·Semin Oncol·2001
6-review
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
PMID 19672973·Pediatr Blood Cancer·2010
3-trial
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
PMID 19458356·Blood·2009
8-other
Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
PMID 19405141·Pediatr Blood Cancer·2009
4-observational
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
PMID 18309945·J Clin Oncol·2008
4-observational
Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
PMID 18334672·Blood·2008
4-observational
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.
PMID 18056841·Blood·2008
8-other
Post-irradiation meningioma with sarcoidosis.
PMID 17361337·J Neurooncol·2007
5-case
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
PMID 17327603·J Clin Oncol·2007
4-observational
Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
PMID 17971588·J Clin Oncol·2007
4-observational
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.
PMID 17485550·Blood·2007
4-observational
Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.
PMID 17218380·Blood·2007
3-trial
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.
PMID 17003366·Blood·2007
2-rct
Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.
PMID 16647567·Exp Hematol·2006
7-preclinical
Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.
PMID 16357833·Leukemia·2006
8-other
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.
PMID 16493009·Blood·2006
3-trial
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
PMID 17010674·Cancer Cell·2006
4-observational
Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
PMID 16267031·Cancer Res·2005
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
450 BROOKLINE AVENUE, ROOM 1642
BOSTON, MA 02215

Location

Practice Location

450 BROOKLINE AVENUE, BOSTON, MA
(617) 632-3316

Quick Facts

NPI
1467421800
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile